Gene · 5819
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells. | iScience | 2023 | 37426355 | PubTator, text mining | PubMed |
| CAR-NK cell therapy for glioblastoma: what to do next? | Front Oncol | 2023 | 37404752 | PubTator, text mining | PubMed |
| Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies. | Genes Dis | 2023 | 37396514 | PubTator, text mining | PubMed |
| PPAD: a deep learning architecture to predict progression of Alzheimer's disease. | Bioinformatics | 2023 | 37387135 | PubTator, text mining | PubMed |
| Ranking the risk factors for Alzheimer's disease; findings from the UK Biobank study. | Aging Brain | 2023 | 37384134 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma. | Front Immunol | 2023 | 37383234 | PubTator, text mining | PubMed |
| Relative Expression of BATF and CD112 in PBMC of Patients with Chronic Lymphocytic Leukemia. | Asian Pac J Cancer Prev | 2023 | 37378949 | PubTator, text mining | PubMed |
| Checkpoint Inhibitors in Acute Myeloid Leukemia. | Biomedicines | 2023 | 37371818 | PubTator, text mining | PubMed |
| TIGIT is a key inhibitory checkpoint receptor in lymphoma. | J Immunother Cancer | 2023 | 37364933 | PubTator, text mining | PubMed |
| DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy. | Front Immunol | 2023 | 37359555 | PubTator, text mining | PubMed |
| Prevailing Antagonistic Risks in Pleiotropic Associations with Alzheimer's Disease and Diabetes. | J Alzheimers Dis | 2023 | 37355909 | PubTator, text mining | PubMed |
| PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma. | Cell Rep | 2023 | 37354459 | PubTator, text mining | PubMed |
| Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints. | Cancers (Basel) | 2023 | 37345111 | PubTator, text mining | PubMed |
| Recent Advances in Molecular Mechanisms of Cancer Immunotherapy. | Cancers (Basel) | 2023 | 37345057 | PubTator, text mining | PubMed |
| Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment. | Cancers (Basel) | 2023 | 37345056 | PubTator, text mining | PubMed |
TIGIT Expression on Activated NK Cells Correlates with Greater Anti-Tumor Activity but Promotes Functional Decline upon Lung Cancer Exposure: Implications for Adoptive Cell Therapy and TIGIT-Targeted Therapies. | Cancers (Basel) | 2023 | 37345049 | PubTator, text mining | PubMed |
| Decoding the genetic relationship between Alzheimer's disease and type 2 diabetes: potential risk variants and future direction for North Africa. | Front Aging Neurosci | 2023 | 37342358 | PubTator, text mining | PubMed |
| Expression and Clinical Significance of TIGIT in Primary Breast Cancer. | Int J Gen Med | 2023 | 37333881 | PubTator, text mining | PubMed |
| A prognostic signature associated with cell senescence predicts survival outcomes and strongly associates with immunotherapy and chemotherapy response in breast cancer. | Medicine (Baltimore) | 2023 | 37327286 | PubTator, text mining | PubMed |
| New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review). | Int J Oncol | 2023 | 37326100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5819/papers?page=20